Active Share (vs S&P 500): 97.9%
· vs QQQ: 98.3%
— share of the book that differs from index weights (higher = more active)
· ranking
Est. Qtr Return (Q2 2026 → Q3 2026):
-14.5%
· vs SPY
-16.6%
· Prev Value $4.25B
— last quarter positions weighted by this quarter price moves
· ranking
Est. QTD Return (Q3 2026 → newest close):
-4.4%
· vs SPY
-6.6%
· Latest Value $3.63B
— latest reported positions valued at quarter-to-date price moves (still in progress)
· ranking
In its Q3 2026 13F filing, EMERALD ADVISERS, LLC disclosed 223 equity positions with a combined reported value of $3.63B. The filing implies a diversified portfolio: its ten largest positions account for 17.6% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.
The largest disclosed positions as of Q3 2026 were TVTX ($92.06M), CORT ($87.37M), IDCC ($73.83M). By sector, the heaviest allocations are Health Care 26.4%, Technology 25.3%. Versus the prior quarter, allocation shifted toward Health Care (+4.7pp), Consumer Staples (+1.1pp) and away from Industrials (-0.7pp), Technology (-1.2pp).
Versus the prior quarter, EMERALD ADVISERS, LLC opened 14 new positions, trimmed 86 and fully exited 28, a turnover rate of 51.0% of positions. The portfolio's overlap with the prior quarter was 83% of names.
The largest new positions opened in Q3 2026 were PRAX ($32.26M), REPL ($27.03M), RDVT ($24.67M).
Of the 28 positions fully exited versus the prior quarter, the largest were SYNA ($37.09M), RMBS ($33.54M), MIR ($24.47M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Latest EMERALD ADVISERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Emerald Advisers is an SEC-registered 13F filer based in Leola, PA, United States. As of Q2 2026 it reported 237 US equity positions with a combined value of $4.25B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Regulatory AUM (Form ADV): $3.30B as of 2026-03-31
Client mix (by RAUM): pension and profit-sharing plans 100%
Website: teamemerald.com
Portfolio Structure
237 positions · $4.25B reported value (Q2 2026)
Top 10 holdings = 17.4% of reported value
Largest position: TVTX (TRAVERE THERAPEUTICS INC) at 2.1%
Average position size: $17.93M
Sector Tilt
Information Technology 26.5%
Health Care 21.7%
Consumer Discretionary 19.5%
(classified holdings cover 99% of value)
Quarterly Activity
Q2 2026: 28 new, 76 added, 81 reduced, 39 exited
52 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
1. Overall direction and market view: The fund is actively rebalancing with a slight tilt toward adding positions (4 adds vs. 3 reduces in top 10), suggesting cautious optimism in select sectors like Health Care, Industrials, and Technology, while trimming some existing holdings.
2. Key moves:
- Added: CORT (+0.87% wt), IDCC (+0.54% wt), SXT (+0.53% wt), MRCY (-0.37% wt, but shares increased), CECO (-0.13% wt, but shares increased).
- Reduced: TVTX (-0.39% wt), COHU (-0.10% wt), SMTC (-0.00% wt, but shares sharply down).
3. Portfolio structure: Active management with a bias toward Health Care (2 top-10 holdings), Industrials (3), and Technology (3). Moderate risk appetite, evidenced by mixed share adjustments and weight changes.
4. Per-holding one-liner:
- TVTX: Biopharma (unverified).
- CORT: Biopharma (unverified).
- IDCC: Wireless tech (unverified).
- SXT: Industrial packaging (unverified).
- COHU: Semiconductor equipment (unverified).
- SMTC: Semiconductor design (unverified).
- PLXS: Electronics manufacturing (unverified).
- MRCY: Defense electronics (unverified).
- VSEC: Industrial services (unverified).
- CECO: Industrial filtration (unverified).
5. Style summary: Active, sector-diversified fund with targeted adds in Health Care/Industrials and trims in semiconductors, balancing growth and value.
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-14 14:57
Every 13F share count is marked to the quarter-end close, rebuilding the NAV this
portfolio would have earned had it done nothing all quarter. This is a historical
reconstruction from already-public filings and prices — not a model forecast, so
precision/recall do not apply.
2023-Q3 = 100. Solid = reconstructed NAV, dashed = SPY benchmark.
Prices are split-adjusted closes and exclude dividends, so dividend-heavy
portfolios would in reality sit slightly above this line.
This portfolio is broadly diversified (Top-10 = 20.2% of reported value), so a
Top-10 proxy cannot represent the whole fund — only the full-holdings reconstruction is shown.
Why there is no forecast NAV
Not published because:
Top-10 covers < 85% of reported value · Holdings-forecast backtest F1 < 0.80 · Top-10 quarterly turnover > 20%
Source: full 13F positions marked to quarter-end closes (computed 2026-11-02 01:13:11).
Share counts and prices are used as a ratio, so splits cancel out.
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical
trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative
volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through
quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q3)
P 60%R 60%F1 60%(modelled on 2026-Q2; 6/10 hit)
Low-confidence forecast
This fund replaces about 41% of its Top-10 each quarter and
backtests at F1 63% (threshold 80%).
Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
Barra Factor Attribution
The disclosed long US equity book from the 2026-Q3 13F is held at its
report-date weights and decomposed over 2026-09-30 ~ 2026-11-12.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
The quarter is not complete yet; the window ends at the latest available price date, 2026-11-12, and will update as prices arrive.
Portfolio return-10.27%Buy & hold
QQQ synthetic benchmark-11.15%Liquidity weighted
Excess return+0.88%vs benchmark
Barra annualised vol36.8%Model estimate
Realised vol42.6%Annualised in window
Weighted beta1.52Raw exposure
Factor / specific risk71% / 29%Share of variance
Top-10 concentration81.5%Of reported value
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
-10.27%
Disclosed long book
QQQ synthetic benchmark
-11.15%
Liquidity-weighted constituents
Model universe, equal weight
+2.04%
Opportunity-cost reference
Excess return
+0.88%
Portfolio − benchmark
Arithmetic return sum
-9.72%
Difference vs compounded is the cross term
Weighted raw beta
1.52
Weighted holding betas
Realised volatility (annualised)
42.56%
Daily returns in window
Barra model volatility (annualised)
36.81%
Factor + specific
Factor share of variance
70.6%
Barra factors
Specific share of variance
29.4%
Stock residuals
Reported value
$523.5M
13F long US equity
2. Return attribution
The -9.72% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
+0.55%
5.7%
Momentum & Growth
3
-1.91%
-19.7%
Volatility & Tail Risk
7
-2.80%
-28.8%
Industry
12
+6.47%
66.5%
Specific
1
-12.04%
-123.8%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Kurtosis
Style
+0.59
+6.17%
+3.67%
37.7%
Health Care
Industry
+0.38
+9.47%
+3.60%
37.0%
Beta
Style
+0.66
+4.92%
+3.25%
33.4%
Residual Volatility
Style
+1.18
+2.15%
+2.53%
26.0%
Size
Style
-0.95
-1.93%
+1.83%
18.9%
Consumer Discretionary
Industry
+0.16
+9.36%
+1.49%
15.3%
Growth
Style
+0.73
+1.50%
+1.10%
11.3%
Communication Services
Industry
+0.10
+10.07%
+1.02%
10.5%
Turnover
Style
-0.22
-4.35%
+0.97%
10.0%
Amihud Illiquidity
Style
+2.24
+0.30%
+0.67%
6.9%
Industrials
Industry
+0.18
+3.55%
+0.64%
6.5%
Max Drawdown
Style
-0.44
-1.01%
+0.45%
4.6%
Non-linear Size
Style
+2.08
+0.07%
+0.14%
1.5%
Leverage (Downside Vol)
Style
-0.04
-3.05%
+0.12%
1.2%
Energy
Industry
+0.01
+9.91%
+0.06%
0.6%
Liquidity
Style
+0.43
-0.20%
-0.09%
-0.9%
Information Technology
Industry
+0.17
-2.11%
-0.35%
-3.6%
Short-term Reversal
Style
-0.53
+1.12%
-0.59%
-6.1%
Skewness
Style
+0.46
-4.77%
-2.19%
-22.5%
Momentum
Style
+0.73
-3.32%
-2.42%
-24.9%
Mid Cap
Style
+1.55
-1.92%
-2.98%
-30.6%
Historical Volatility
Style
+1.08
-9.82%
-10.62%
-109.2%
Specific
Specific
—
—
-12.04%
-123.8%
3. Risk attribution
Annualised volatility is 36.81%; factor risk explains 70.6% of variance and specific risk 29.4%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Specific
Specific
—
29.4%
+10.82%
10.8%
Historical Volatility
Style
+1.08
14.4%
+5.29%
5.3%
Beta
Style
+0.66
8.7%
+3.19%
3.2%
Mid Cap
Style
+1.55
8.2%
+3.03%
3.0%
Residual Volatility
Style
+1.18
5.6%
+2.05%
2.0%
Health Care
Industry
+0.38
4.9%
+1.81%
1.8%
Industrials
Industry
+0.18
4.5%
+1.65%
1.6%
Non-linear Size
Style
+2.08
3.8%
+1.39%
1.4%
Amihud Illiquidity
Style
+2.24
3.7%
+1.37%
1.4%
Information Technology
Industry
+0.17
3.6%
+1.31%
1.3%
Size
Style
-0.95
3.0%
+1.11%
1.1%
Growth
Style
+0.73
2.9%
+1.06%
1.1%
Consumer Discretionary
Industry
+0.16
2.8%
+1.03%
1.0%
Momentum
Style
+0.73
2.0%
+0.76%
0.8%
Communication Services
Industry
+0.10
1.8%
+0.67%
0.7%
Short-term Reversal
Style
-0.53
0.9%
+0.32%
0.3%
Liquidity
Style
+0.43
0.6%
+0.21%
0.2%
Kurtosis
Style
+0.59
-1.1%
-0.39%
-0.4%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
-0.95
+2.10
-3.05
Non-linear Size
+2.08
+1.68
+0.40
Mid Cap
+1.55
+0.13
+1.43
Beta
+0.66
+1.29
-0.63
Momentum
+0.73
+0.72
+0.01
Short-term Reversal
-0.53
-0.64
+0.11
Residual Volatility
+1.18
-0.40
+1.58
Historical Volatility
+1.08
+0.86
+0.22
Liquidity
+0.43
+0.11
+0.31
Amihud Illiquidity
+2.24
+1.16
+1.08
Turnover
-0.22
+0.21
-0.43
Growth
+0.73
+0.58
+0.15
Leverage (Downside Vol)
-0.04
+0.14
-0.18
Skewness
+0.46
+0.24
+0.22
Kurtosis
+0.59
+0.21
+0.38
Max Drawdown
-0.44
-0.08
-0.36
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Information Technology
16.6%
73.6%
-4.16%
-16.67%
+3.57%
+9.21%
-7.13%
+11.58%
Utilities
0.5%
0.8%
+4.23%
+10.14%
-0.05%
-0.05%
+0.01%
-0.06%
Consumer Staples
0.0%
0.8%
+0.00%
+15.33%
-0.22%
-0.13%
+0.13%
-0.13%
Energy
0.6%
0.1%
-24.37%
-1.54%
+0.04%
-0.03%
-0.10%
-0.13%
Communication Services
10.1%
2.6%
-10.95%
-12.15%
-0.13%
+0.03%
+0.09%
-0.79%
Consumer Discretionary
15.9%
8.8%
-9.68%
+5.93%
+1.16%
-1.38%
-1.11%
-2.06%
Industrials
17.9%
11.1%
-9.34%
+7.87%
+1.25%
-1.91%
-1.17%
-2.55%
Health Care
38.0%
1.7%
-14.83%
+9.50%
+7.23%
-0.42%
-8.83%
-5.81%
Total
+12.80%
+5.29%
-18.14%
-0.05%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
CORT
CORCEPT THERAPEUTICS INC
Health Care
16.69%
-35.32%
-5.90%
Add
CECO
CECO ENVIRONMENTAL CORP
Industrials
9.96%
-5.49%
-0.55%
Add
LIVN
LIVANOVA PLC
Health Care
9.92%
+18.93%
+1.88%
Reduce
ESE
ESCO TECHNOLOGIES INC
Communication Services
9.56%
-9.67%
-0.92%
Add
GH
GUARDANT HEALTH INC
Health Care
9.32%
-13.22%
-1.23%
Reduce
SEI
SOLARIS ENERGY INFRAS INC
Consumer Discretionary
8.91%
-8.96%
-0.80%
Add
AGX
ARGAN INC
Consumer Discretionary
5.79%
-14.80%
-0.86%
Reduce
ALMR
ALAMAR BIOSCIENCES INC
Industrials
5.12%
-7.22%
-0.37%
Add
AAOI
APPLIED OPTOELR
Information Technology
3.47%
+10.46%
+0.36%
Reduce
NVDA
NVIDIA CORPORATION
Information Technology
2.78%
-23.93%
-0.67%
Add
ONTO
ONTO INNOVATION INC
Industrials
1.96%
-30.13%
-0.59%
Reduce
AAPL
APPLE INC
Information Technology
1.37%
+6.79%
+0.09%
Add
MSFT
MICROSOFT CORP
Information Technology
1.30%
+1.60%
+0.02%
Add
TWST
TWIST BIOSCIENCE CORP
Health Care
1.24%
-36.56%
-0.46%
New
TTAN
SERVICETITAN INC
Information Technology
1.21%
+24.37%
+0.30%
New
GOOGL
ALPHABET INC
Information Technology
1.16%
-14.71%
-0.17%
Hold
AVGO
BROADCOM INC
Information Technology
0.74%
-1.70%
-0.01%
Hold
CRDO
CREDO TECHNOLOGY GROUP HOLDI
Information Technology
0.72%
-27.40%
-0.20%
Hold
TTWO
TAKE-TWO INTERACTIVE SOFTWAR
Information Technology
0.63%
+11.47%
+0.07%
Add
DDOG
DATADOG INC
Information Technology
0.63%
-32.67%
-0.21%
Reduce
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
LIVN
Health Care
9.92%
+18.93%
+1.88%
2
AAOI
Information Technology
3.47%
+10.46%
+0.36%
3
TTAN
Information Technology
1.21%
+24.37%
+0.30%
4
AAPL
Information Technology
1.37%
+6.79%
+0.09%
5
LLY
Health Care
0.31%
+24.22%
+0.07%
6
TTWO
Information Technology
0.63%
+11.47%
+0.07%
7
V
Consumer Discretionary
0.15%
+18.43%
+0.03%
8
COST
Consumer Discretionary
0.13%
+19.47%
+0.03%
9
SEI
Consumer Discretionary
8.91%
-8.96%
-0.80%
10
AGX
Consumer Discretionary
5.79%
-14.80%
-0.86%
11
ESE
Communication Services
9.56%
-9.67%
-0.92%
12
GH
Health Care
9.32%
-13.22%
-1.23%
13
CORT
Health Care
16.69%
-35.32%
-5.90%
7. Conclusions
Over the attribution window 2026-09-30 → 2026-11-12 (31 trading days), the reported portfolio returned -10.27%, versus -11.15% for the QQQ synthetic benchmark — an excess of +0.88%.
Return attribution: the largest positive style/industry contributions came from Kurtosis +3.67%, Health Care +3.60%, Beta +3.25%; the largest drags came from Historical Volatility -10.62%, Mid Cap -2.98%, Momentum -2.42%. Specific (stock-level) return contributed -12.04%.
Risk attribution: Barra model volatility is 36.81% annualised; factor risk explains 71% of variance and specific risk 29%. The largest factor risk sources are Historical Volatility 14.4%, Beta 8.7%, Mid Cap 8.2%.
Style tilt: size -0.95, momentum +0.73, volatility +1.08, liquidity +0.43; the weighted raw beta is 1.52. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Health Care (+36.3 pp), the largest underweight is Information Technology (-57.0 pp). Allocation contributed +12.80%, selection +5.29% and interaction -18.14%.
Concentration: the top-10 positions are 81.5% of the attributed portfolio and the model covers 98.8% of its value with full style exposures; the remainder is mapped to its sector only. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did EMERALD ADVISERS, LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, EMERALD ADVISERS, LLC reported 223 equity positions worth $3.63B in aggregate; its largest disclosed positions were TVTX ($92.06M), CORT ($87.37M), IDCC ($73.83M).
How large is EMERALD ADVISERS, LLC's portfolio?
EMERALD ADVISERS, LLC reported $3.63B of long equity holdings across 223 positions as of 2026-Q3. Top-10 holdings account for 17.6% of reported value.
What is EMERALD ADVISERS, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/emerald-advisers/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>